Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 3468
  • Home
  • Print this page
  • Email this page

   Table of Contents      
BRIEF COMMUNICATION
Year : 2013  |  Volume : 61  |  Issue : 4  |  Page : 179-182

Traumatic chorioretinal folds treated with intra-vitreal triamcinolone injection


1 Department of Ophthalmology, KyungHee University Medical Center, College of Medicine, KyungHee University, Seoul, Korea
2 Department of Ophthalmology, Inje University Seoul Paik Hospital, College of Medicine, Inje University, Seoul, Korea

Date of Submission08-Jul-2012
Date of Acceptance24-Dec-2012
Date of Web Publication17-May-2013

Correspondence Address:
Seung-Young Yu
Department of Ophthalmology, Kyung Hee University Medical Center, Hoegi-dong, Dongdaemoon-gu, Seoul, Korea, Postal code: 130-872
Korea
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0301-4738.112165

Rights and Permissions
  Abstract 

A 34-year-old male visited the hospital due to decreased visual acuity in the left eye following an injury from a car accident. In the left eye, best-corrected visual acuity (BCVA) was hand motion and intraocular pressure (IOP) was 8 mmHg. Choroidal vasodilation and chorioretinal folds were observed by spectral domain-optical coherence tomography (SD-OCT). Topical and systemic steroid treatments did not improve the chorioretinal folds. Twelve months after the injury, intra-vitreal triamcinolone (4 mg/0.1 ml) was injected. Six months after intra-vitreal triamcinolone injection, BCVA in the left eye had improved to 20/100. Fundus examination showed improvement in retinal vascular tortuosity and SD-OCT revealed improvements in choroidal vasodilation and chorioretinal folds. Intra-vitreal triamcinolone injection (IVTI) was effective against traumatic chorioretinal folds with no recurrence based on objective observation by fundus photography and SD-OCT.

Keywords: Chorioretinal folds, intra-vitreal triamcinolone injection, spectral domain-optical coherence tomography


How to cite this article:
Kim KY, Kwak HW, Kim M, Yu SY. Traumatic chorioretinal folds treated with intra-vitreal triamcinolone injection. Indian J Ophthalmol 2013;61:179-82

How to cite this URL:
Kim KY, Kwak HW, Kim M, Yu SY. Traumatic chorioretinal folds treated with intra-vitreal triamcinolone injection. Indian J Ophthalmol [serial online] 2013 [cited 2019 Nov 18];61:179-82. Available from: http://www.ijo.in/text.asp?2013/61/4/179/112165

Chorioretinal folds are a rare condition resulting from undulations in the choriocapillaris, Bruch's membrane, retinal pigment epithelium (RPE), and sensory retina. Chorioretinal folds can be idiopathic or due to orbital tumor, thyroid disorder, orbital cellulitis, papilledema, hypotony, scleritis, retinal detachment, uveitis, sclera buckling, or trauma. The exact pathogenesis of chorioretinal folds is unclear. Newell [1] suggested that the folds occur due to the attachment of the Bruch's membrane to the choriocapillaris and factors causing congestion in the choriocapillaris. Friberg [2] postulated that chorioretinal folds are caused by direct tension exerted at Bruch's membrane, which destroys the balance of choroidal tensile force in the choroid with a normal intraocular pressure (IOP). Management of chorioretinal folds varies depending on etiology. Thus, for proper management it is critical to determine the etiology through diagnostic tests.

To our knowledge, this is the first reported case of traumatic chorioretinal folds that did not respond to systemic steroid treatment but improved after intra-vitreal triamcinolone injection (IVTI) based on objective observation by fundus photography and spectral domain-optical coherence tomography (SD-OCT).


  Case Report Top


A 34-year-old male was injured in a car accident. Facial computed tomography showed multiple facial fractures [Figure 1]a. Best-corrected visual acuity (BCVA) was 20/20 in the right eye and 10-cm hand motion in the left eye. Spherical equivalents were -1.25 D in the right eye and -6.50 D in the left eye, which showed myopic changes. IOP was 17 mmHg in the right eye and 8 mmHg in the left eye. Fundus examination revealed vitreous hemorrhage and retinal hemorrhage. SD-OCT (Cirrus HD-OCT, Carl Zeiss Meditec, Dublin, CA, USA) showed a lamellar macular hole [Figure 2]a.
Figure 1: (a) Pre-operative facial computed tomography scan showing multiple fractures of the left inferior and maxillary sinus wall, and intact eyeball, (b) Postoperative facial computed tomography scan showing fixation of the fracture sites with titanium plates and screws, and Medpore®

Click here to view
Figure 2: (a) At initial presentation, fundus photography and SD-OCT of the left eye showing vitreous hemorrhage, retinal hemorrhage, and lamellar macular hole, (b) At 1 month after the initial trauma, fundus photography showing retinal vascular tortuosity and chorioretinal folds. OCT shows the wavy appearance of the hyper-reflective line corresponding to the retinal pigment epithelium as well as the underlying choroid. The white arrows indicate choroidal vasodilation

Click here to view


Three days after the injury, BCVA was 20/2000 and IOP was 9 mmHg in the left eye, and SD-OCT showed chorioretinal folds and choroidal vasodilation. Two weeks after the injury, facial reconstruction for multiple facial fractures was performed at the department of plastic surgery in our hospital [Figure 1]b. One month after the injury, fundus examination revealed constant chorioretinal folds, vitreous hemorrhage, retinal vascular tortuosity, and SD-OCT showed undulations of the RPE-Bruch's membrane complex and choroidal vasodilation in the posterior pole, and no progression of lamellar hole to full-thickness macular hole [Figure 2]b.

Treatment with topical prednisolone acetate and systemic prednisolone (30 mg/day) for 3 months led to absorption of the vitreous hemorrhage but no improvement in visual acuity, IOP, or chorioretinal folds, and spherical equivalents changed to -0.50 D in the left eye. After 12 months of treatment there was still no significant change in BCVA. Fundus examination showed retinal vascular tortuosity and continuous chorioretinal folds in the posterior pole region of the left eye [Figure 3]a. The young patient wanted no more delay in treatment and hoped for more aggressive treatment. Through full explanation of the expected effects and possible complications of IVTI, informed consent was obtained from the patient before injection and intra-vitreal injections were performed using standard techniques. One week after IVTI (4 mg/0.1 ml), BCVA was 20/400 and IOP was 8 mmHg in the left eye. Six months after injection, BCVA was 20/100 and IOP was 14 mmHg in the left eye. Fundus photography revealed that retinal vascular tortuosity had disappeared and SD-OCT showed improvement of the chorioretinal folds and choroidal vasodilation [Figure 3]b.
Figure 3: (a) Autofluorescence image pre-IVTI showing an alternating pattern of light and dark bands, as well as linear bead-like areas of hyper-autofluorescence. SD-OCT showing the wavy appearance of the hyper-reflective line corresponding to the retinal pigment epithelium as well as the underlying dilated choroidal vessels, (b) Autofluorescence image post-IVTI showing improved alternating pattern of light and dark bands as well as linear beadlike areas of hyper-autofluorescence. SD-OCT showing flattened retinal pigment epithelium, improved chorioretinal folds, dilated choroidal vessels, and formation of epiretinal membranes

Click here to view



  Discussion Top


Chorioretinal folds develop as a result of various conditions such as orbital tumor, thyroid ophthalmopathy, pseudotumor, orbital cellulitis, papilledema, hypotony, choroidal melanoma, scleritis, retinal detachment, uveitis, sclera buckling, uveal effusion, or trauma. The mechanism underlying the development of the chorioretinal folds, however, is unknown. [1],[2] Based on ultrasound, Cappaert et al. [3] suggested that scleral thickening and subsequent shrinkage have a role in the development of chorioretinal folds. Bullock and Egbert [4] concluded that forces compressing the Bruch's membrane as well as the adjacent RPE layer and choriocapillaris layer lead to the folds.

Chorioretinal folds are usually narrow and located posterior to the equator with alternating dark and light bands. Most of the folds are orientated horizontally and point toward the optic disc, although they can also have vertical, oblique, irregular, and reticular patterns, and generally do not extend past the equator. The pattern of light and dark bands shown by fluorescein angiography may be explained by differences in RPE density. The banding patterns are inverted between fluorescein angiographic and autofluorescence images. [5]

This case showed continuous folds of the RPE-Bruch's membrane complex. Hypotony and cyclodialysis cleft cause chorioretinal folds. Although ultrasound biomicroscopy (UBM) did not show the definite cyclodialysis cleft, myopic changes in refractive index and phacodonesis were observed in comparison with the contralateral eye, which may be due to ciliary damage and a lasting low IOP associated with blunt trauma. [6]

Kohno et al. [7] postulated that trauma to the eye, even when relatively mild, causes various types of injury to the choroidal vessels, such as delayed filling in choroidal veins, intra-choroidal leakage, delayed filling of the choroidal arteries, and changes in the choroidal vasculature together with impairment of the choriocapillaris observed on indocyanine green angiography (ICGA). In the present case, the choroidal vasodilation observed on SD-OCT might be related to choroidal vessel congestion, which is a predisposing factor for development of chorioretinal folds.

One treatment option for chorioretinal folds is administration of systemic steroids, which reduce the permeability of the outer blood-retinal barrier, induce resorption of exudation, and downregulate inflammatory stimuli. In this case, systemic steroids for 3 months did not affect the chorioretinal folds, whereas a single dose of IVTI (4 mg/0.1 ml) led to improvement of the chorioretinal folds as observed by SD-OCT. A higher therapeutic concentration in the vitreous can be achieved with IVTI compared with systemic steroid therapy, affecting not only the inner and outer retinal layers, but also the choroidal vessels, which do not respond to systemic steroid therapy. Triamcinolone acetonide has the capacity to reduce adhesion molecule expression and permeability of choroidal vessels, and exhibits vasoconstrictive effects that may contribute to its effectiveness in treating ocular neovascularization. [8],[9] In addition, that increased IOP caused by IVTI has contributed to the resolution of chorioretinal folds is considered.

In conclusion, IVTI induced the regression of traumatic chorioretinal folds due to reduction of permeability of the choroidal vessels, inflammatory reaction, and increased IOP. Therefore, IVTI is a considerable treatment option when traumatic chorioretinal folds do not respond to conservative treatment. The efficacy of IVTI in chorioretinal folds was observed objectively by fundus photography and SD-OCT in this case.


  Acknowledgment Top


Written consent was obtained from the patient for publication of this study.

 
  References Top

1.
Newell FW. Choroidal folds. The seventh Harry Searls Gradle Memorial lecture. Am J Ophthalmol 1973;75:930-42.  Back to cited text no. 1
[PUBMED]    
2.
Friberg TR. The etiology of choroidal folds. A biomechanical explanation. Graefes Arch Clin Exp Ophthalmol 1989;227:459-64.  Back to cited text no. 2
[PUBMED]    
3.
Cappaert WE, Purnell EW, Frank KE. Use of B-sector scan ultrasound in the diagnosis of benign choroidal folds. Am J Ophthalmol 1977;84:375-9.   Back to cited text no. 3
[PUBMED]    
4.
Bullock JD, Egbert PR. Experimental choroidal folds. Am J Ophthalmol 1974;78:618-23.   Back to cited text no. 4
[PUBMED]    
5.
Fine HF, Cunningham ET, Kim E, Theodore Smith R, Chang S. Autofluorescence imaging findings in long-standing chorioretinal folds. Retin Cases Brief Rep 2009;3:137-9.  Back to cited text no. 5
[PUBMED]    
6.
Ioannidis AS, Barton K. Cyclodialysis cleft: Causes and repair. Curr Opin Ophthalmol 2010;21:150-4.  Back to cited text no. 6
[PUBMED]    
7.
Kohno T, Miki T, Hayashi K. Choroidopathy after blunt trauma to the eye: A fluorescein and indocyanine green angiographic study. Am J Ophthalmol 1998;126:248-60.  Back to cited text no. 7
[PUBMED]    
8.
Jermak CM, Dellacroce JT, Heffez J, Peyman GA. Triamcinolone acetonide in ocular therapeutics. Surv Ophthalmol 2007;52:503-22.  Back to cited text no. 8
[PUBMED]    
9.
Tao Y, Jonas JB. Intravitreal triamcinolone. Ophthalmologica 2011;225:1-20.  Back to cited text no. 9
[PUBMED]    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
Case Report
Discussion
Acknowledgment
References
Article Figures

 Article Access Statistics
    Viewed2317    
    Printed19    
    Emailed0    
    PDF Downloaded121    
    Comments [Add]    

Recommend this journal